Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

Treatment Form Kidney Cancer (NCT01198158)

- 08.01.15 - 1 Formular, 6 Itemgruppen, 39 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Patient Information, Urinalysis Day 1, Urinalysis Day 15, Everolimus, Bevacizumab/Placebo Information

CALGB 90802 Treatment Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy NCT01198158 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=87963E33-F0BE-4A17-E040-BB89AD433B67

Treatment Form Breast Cancer Adriamycin, Cyclophosphamide (NCT00087178)

- 05.01.15 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Header Section, Adriamycin and Cyclophosphamide

NSABP PROTOCOL B-36 Treatment Form for Adriamycin, Cyclophosphamide (AC) Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer NCT00087178 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C87B5EFD-2DE6-59DF-E034-0003BA12F5E7

Treatment Form Liver Cancer CALGB 80802

- 03.01.15 - 1 Formular, 2 Itemgruppen, 32 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Treatment Data

CALGB: 80802 Treatment Form Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer NCT01015833 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=741A6270-CE1B-C531-E040-BB89AD431F2C

Brain and Central Nervous System Tumors NCT00978458 Treatment - E3F05 Chemotherapy Form - Arm B Only - 2904374v1.0 - Chemotherapy Form Glioma (Arm B, E3F05)

- 01.01.15 - 1 Formular, 5 Itemgruppen, 31 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Vital Status, Patient Characteristics, Therapy Administered, Non-Protocol Therapy

E3F05 Chemotherapy Form - Arm B Only Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma NCT00978458 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6D055B43-63F1-A6F7-E040-BB89AD436A92

Induction Treatment Form Multiple Myeloma (E1A06)

- 01.01.15 - 1 Formular, 10 Itemgruppen, 78 Datenelemente, 1 Sprache

Itemgruppen: Header section, Vital Status, Patient Characteristics, Therapy Administered - Melphalan, Therapy Administered - Prednisone, Therapy Administered - Thalidomide, Therapy Administered - Prophylaxis Treatment, Therapy Administered - Lenalidomide, Non-Protocol Therapy, Comments

E1A06 Induction Treatment Form Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00602641 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=402A1AE1-FA70-56B0-E044-0003BA3F9857

Treatment Form Multiple Myeloma (Form 2860)

- 01.01.15 - 1 Formular, 9 Itemgruppen, 59 Datenelemente, 1 Sprache

Itemgruppen: Header section, Vital Status, Patient Characteristics, Therapy Administered - Section I, Therapy Administered - Section II, Therapy Administered - Section III, Other Therapy Administered, Non-Protocol Therapy, Comments

E1A05 Treatment Form - Form 2860 Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone NCT00522392 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=32B65860-B480-5012-E044-0003BA3F9857

Treatment Form Multiple Myeloma E3A06 Arm A

- 01.01.15 - 1 Formular, 6 Itemgruppen, 40 Datenelemente, 1 Sprache

Itemgruppen: Header Module, ON TREATMENT, Vital Status, Patient Characteristics, Therapy Administered, Non-Protocol Therapy

E3A06 Treatment Form (Arm A) Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma NCT01169337 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=86D1B322-221A-3014-E040-BB89AD432E00

Treatment Form Multiple Myeloma Maintenance E1A06

- 01.01.15 - 1 Formular, 9 Itemgruppen, 60 Datenelemente, 1 Sprache

Itemgruppen: Header section, ON TREATMENT, Vital Status, Patient Characteristics, Therapy Administered - Thalidomide, Therapy Administered - Lenalidomide, Prophylaxis Treatment, Non-Protocol Therapy, Comments

E1A06 Maintenance Treatment Form Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4066DEFA-0353-324B-E044-0003BA3F9857

Treatment - PHASE II LUNG CANCER ¿ TREATMENT BY CYCLE SUMMARY FORM - 2400140v1.0 - Treatment by cycle summary form (Lung Cancer)

- 30.12.14 - 1 Formular, 6 Itemgruppen, 47 Datenelemente, 1 Sprache

Itemgruppen: Header section, Treatment Plan, Concomitant Medications, Radiation Therapy, Systemic Therapy, Comments

Phase II Consortium - PHASE II LUNG CANCER - TREATMENT BY CYCLE SUMMARY FORM Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF93BE54-D125-5058-E034-0003BA3F9857

Tag 35 nach Beginn der letzten Induktionstherapie

- 22.12.14 - 1 Formular, 1 Itemgruppe, 4 Datenelemente, 2 Sprachen

Itemgruppe: Regeneration of blood cell count

A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML

Treatment - Hematopoietic Stem Cell Transplant (HSCT) Infusion ISO Date Format Version 1 - 2894050v2.0 - FP.0000

- 18.12.14 - 1 Formular, 25 Itemgruppen, 235 Datenelemente, 1 Sprache

Itemgruppen: Registry Use Only, Identification Data, HSCT Type, Product Type, Pre-Collection Therapy, Product Collection - Part 1 / 2, Product Collection - Part 2 / 2, Product Transport and Receipt, Product Processing / Manipulation - Part 1 / 2, Product Processing / Manipulation - Part 2 / 2, Autologous Products Only - Part 1 / 5, Autologous Products Only - Part 2 / 5, Autologous Products Only - Part 3 / 5, Autologous Products Only - Part 4 / 5, Autologous Products Only - Part 5 / 5, Product Analysis (All Products), Product Infusion - Part 1 / 5, Product Infusion - Part 2 / 5, Product Infusion - Part 3 / 5, Product Infusion - Part 4 / 5, Product Infusion - Part 5 / 5, Donor Demographic Information - Part 1 / 3, Donor Demographic Information - Part 2 / 3, Donor Demographic Information - Part 3 / 3, Author Information

Hematopoietic Stem Cell Transplant (HSCT) Infusion ISO Date Format Version 1 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Dental Caries Treatment - PRL0501 - Path NE (No pulp exposure anticipated) - 2444306v1.0 - PRL0501 - Path NE (No pulp exposure anticipated)

- 18.12.14 - 1 Formular, 5 Itemgruppen, 73 Datenelemente, 1 Sprache

Itemgruppen: Deep Caries Patient Scenario, Path NE (No pulp exposure anticipated), Path NE-A -- Remove all decay, Path NE-B -- Do not remove all decay, Path NE-C -- Refer for Endodontic Treatment

PRL0501 - Path NE (No pulp exposure anticipated) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0B58CA14-D33D-40B8-E044-0003BA3F9857

Stichworte

Inhaltsverzeichnis

Ausgewählte Datenmodelle